Discover
QNRX
Quoin Pharmaceuticals, Ltd.
4.79
1 x 4.57
1 x 4.88
bid
ask
+
0.22
4.81%
30 @ 04:00 PM
4.70 -0.09 (1.88%)
| Ytd | -66.81% | |
| 1y | -30.68% |
4.70
day range
4.90
3.25
52 week range
22.30
| Open | 4.79 | Prev Close | 4.57 | Low | 4.70 | High | 4.90 | Mkt Cap | 9.62M |
| Vol | 17.25K | Avg Vol | 252.88K | EPS | -29.56 | P/E | -0.16 | Forward P/E | -0.43 |
| Beta | 1.89 | Short Ratio | 0.20 | Inst. Own | 5.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 4.49 | 200-d Avg | 8.78 | 1yr Est | 4.50 |
| Income Statement | |||
| Operating Expenses | 5.13M | ||
| Research and Development Expense | 3.43M | ||
| Selling, General and Administrative Expense | 1.70M | ||
| Operating Income | -5.13M | ||
| Net Income | -5.00M | ||
| Net Income Common Stock | -5.00M | ||
| Net Income Common Stock (USD) | -5.00M | ||
| Consolidated Income | -5.00M | ||
| Earning Before Interest & Taxes (EBIT) | -5.00M | ||
| Earning Before Interest & Taxes (USD) | -5.00M | ||
| Weighted Average Shares | 63.13M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.12M | ||
| Cash and Equivalents (USD) | 3.12M | ||
| Investments | 10.92M | ||
| Investments Current | 10.92M | ||
| Current Assets | 15.33M | ||
| Total Assets | 15.69M | ||
| Current Liabilities | 5.35M | ||
| Total Liabilities | 6.92M | ||
| Accumulated Retained Earnings (Deficit) | -75.97M | ||
| Accumulated Other Comprehensive Income | -159.00 | ||
| Shareholders Equity | 8.77M | ||
| Shareholders Equity (USD) | 8.77M | ||
| Assets Non-Current | 358.33K | ||
| Goodwill and Intangible Assets | 358.33K | ||
| Liabilities Non-Current | 1.57M | ||
| Trade and Non-Trade Payables | 1.78M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 25.00K | ||
| Net Cash Flow from Financing | 55.98K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -693.57K | ||
| Issuance (Purchase) of Equity Shares | 205.98K | ||
| Issuance (Repayment) of Debt Securities | -150.00K | ||
| Net Cash Flow from Investing | 4.12M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.12M | ||
| Net Cash Flow from Operations | -4.87M | ||
| Effect of Exchange Rate Changes on Cash | 454.00 | ||
| Share Based Compensation | 444.53K | ||